Overview

Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Our head office and laboratories are located in Mississauga, Ontario, Canada. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) we develop products that we sell under Covalon’s name; and, (ii) we develop and commercialize medical products for other medical companies under development and license contracts.  The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF.  Covalon is incorporated under the laws of Ontario.

Stock Info
TSXVCOV
Press Releases
Jul 29, 2021

Purchase and sale agreement executed with simultaneous closing with TIDI Products, LLC as buyer The transaction materially improves Covalon's balance sheet to an estimated net cash position of...

Jul 2, 2021

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, announced today the results of the matters voted upon at its Fiscal...

May 31, 2021

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2021 second quarter results for the period ended

View All

Email Alerts
* Required Fields
Events
Monday, May 31, 2021
9:00am EDT
Thursday, November 12, 2020
3:30pm EST

View All

Contact Us

For investor relations inquiries, please contact Brian Pedlar (CEO).
e-mail: bpedlar@covalon.com

 

To contact the Board of Directors to provide comments, report concerns or ask a question, please contact Abe Schwartz (Chair of the Board).
e-mail: abe@covalon.com

Contact Form